Clinical Implementation of Pharmacogenetics: More than One Gene at a Time by Johnson J A, Klein T E, Relling M V in Clinical pharmacology and therapeutics (2013). PubMed

Abstract

Tricyclic antidepressant (TCA) clinical pharmacogenetic implementation guidelines for CYP2D6 and CYP2C19 genotypes highlight the importance of both genes. However, studies of the combined impact of the two genes are sparse, limiting the ability to make strong recommendations based on both genes. The warfarin pharmacogenetics literature highlights the strength of a multigenic approach for discovery and clinical implementation. For optimal impact and interpretation, investigators are encouraged to conduct studies in the context of previously well-defined pharmacogenetics markers.

[ hide abstract ]

Discussed In Paper